Gynozol (Miconazole Nitrate)

Gynozol is indicated for the treatment of fungal infections of the female genital tract. It is commonly prescribed for the following conditions:

• Vulvovaginal candidiasis (yeast infection of the vagina)
• Prevention of recurrent vaginal yeast infections
• Treatment of mild to moderate vaginal fungal overgrowth
• Adjunct therapy in mixed bacterial‑fungal vaginal infections
• Symptomatic relief of itching, burning, and abnormal discharge caused by Candida species

Side effects of Gynozol are generally mild and related to local application, but serious reactions can occur in rare cases.

Common

• Vaginal irritation or burning sensation
• Itching at the site of application
• Mild vaginal discharge or spotting
• Unpleasant odor from the product
• Headache
• Nausea

Serious

• Severe allergic reaction (rash, swelling, difficulty breathing)
• Persistent vaginal irritation or ulceration
• Signs of secondary infection (fever, foul odor, worsening discharge)
• Unusual vaginal bleeding

Before using Gynozol, consider the following precautions to ensure safe and effective treatment:

• Confirm the diagnosis of a fungal infection; avoid use for bacterial vaginosis or other conditions.
• Do not use if you have a known hypersensitivity to miconazole or any imidazole antifungal.
• Consult a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.
• Avoid using the product if you have an active vaginal ulcer or severe irritation.
• Discontinue use and seek medical advice if symptoms persist beyond the recommended treatment period.
• Keep the product out of reach of children and store at room temperature away from moisture.

Gynozol may interact with other medications or substances applied vaginally. Consider the following interaction guidance:

Avoid

• Concurrent use of other intravaginal antifungal or hormonal products without medical advice.
• Use with vaginal douches, spermicides, or lubricants that may alter drug absorption.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase systemic exposure.
• Topical corticosteroids applied to the same area, which could mask irritation.
• Antibiotics that disrupt normal vaginal flora, potentially affecting treatment efficacy.
• Herbal vaginal suppositories or creams, as they may cause unpredictable reactions.